Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-11 3:11 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | JANUS HENDERSON GROUP PLC JHG | 5,055,099 5.5% | 5,055,099 (New Position) | View |
| 2022-02-10 08:37 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | VANGUARD GROUP INC | 4,676,265 5.09% | 4,676,265 (New Position) | View |
| 2022-02-09 10:24 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 13,777,070 14.999% | 2,440,497 (+21.53%) | View |
| 2022-02-04 06:09 am Sale | 13G | SERES THERAPEUTICS INC MCRB | Sumitomo Mitsui Trust Holdings Inc. | 785,519 0.85% | -5,038,084 (-86.51%) | View |
| 2022-02-03 4:41 pm Sale | 13G | SERES THERAPEUTICS INC MCRB | BlackRock Inc. BLK | 5,862,691 6.4% | -411,145 (-6.55%) | View |
| 2022-01-10 10:46 am Sale | 13G | SERES THERAPEUTICS INC MCRB | STATE STREET CORP STT | 4,785,589 5.21% | -5,217,802 (-52.16%) | View |
| 2021-10-12 12:39 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | STATE STREET CORP STT | 10,003,391 10.91% | 10,003,391 (New Position) | View |
| 2021-05-05 4:39 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | RA CAPITAL MANAGEMENT L.P. | 4,702,206 5.1% | 4,702,206 (New Position) | View |
| 2021-02-16 4:33 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | ARK Investment Management LLC | 13,741,254 15.06% | 1,448,221 (+11.78%) | View |
| 2021-02-11 5:26 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | Nikko Asset Management Americas Inc. | 5,823,603 6.38% | 198,613 (+3.53%) | View |
| 2021-02-08 10:33 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 11,336,573 12.423% | 536,073 (+4.96%) | View |
| 2021-02-05 06:10 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | Sumitomo Mitsui Trust Holdings Inc. | 5,823,603 6.38% | 198,613 (+3.53%) | View |
| 2021-02-01 08:30 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | BlackRock Inc. BLK | 6,273,836 6.9% | 2,270,483 (+56.71%) | View |
| 2020-11-25 4:30 pm Sale | 13D | SERES THERAPEUTICS INC MCRB | Flagship VentureLabs IV LLC | 15,049,991 16.5% | -6,596,914 (-30.48%) | View |
| 2020-10-09 2:17 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | ARK Investment Management LLC | 12,293,033 13.77% | 5,019,193 (+69.00%) | View |
| 2020-09-10 10:03 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 10,800,500 12.095% | 4,301,382 (+66.18%) | View |
| 2020-09-09 06:03 am Sale | 13G | SERES THERAPEUTICS INC MCRB | Sumitomo Mitsui Trust Holdings Inc. | 5,624,990 6.3% | -2,648,233 (-32.01%) | View |
| 2020-09-08 1:28 pm Sale | 13G | SERES THERAPEUTICS INC MCRB | Nikko Asset Management Americas Inc. | 5,624,990 6.3% | -2,648,233 (-32.01%) | View |
| 2020-08-19 5:17 pm Purchase | 13D | SERES THERAPEUTICS INC MCRB | Nestle Health Science US Holdings Inc. | 7,892,890 8.8% | 993,689 (+14.40%) | View |
| 2020-02-14 11:43 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | ARK Investment Management LLC | 7,273,840 10.39% | 3,154,361 (+76.57%) | View |